We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DRI:NYSEDarden Restaurants, Inc. Analysis

Data as of 2026-06-16 - not real-time

$210.41

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Darden Restaurants (DRI) is trading at $210.41, comfortably above its 20‑day SMA of 202.09 and the 50‑day SMA of 198.77, with the 200‑day SMA at 195.81, confirming a sustained bullish trend. The RSI of 62 and a bullish MACD histogram (+1.22) reinforce upward momentum, while the stock remains above its key support at $189.97 and below resistance at $214.14, offering a clear upside corridor. Volatility is elevated at roughly 25% over the past 30 days, yet the beta of 0.34 indicates the share moves less than the broader market, and volume has stayed stable, supporting liquidity.
Fundamentally, DRI posted 5.9% revenue growth YoY with solid operating (13.2%) and profit margins (8.7%). An extraordinary ROE of 51.5% reflects efficient earnings generation, but a debt‑to‑equity ratio exceeding 380% signals leverage risk. The company pays a $6 dividend yielding 2.87% and a payout ratio of 62%, backed by $678 M of free cash flow, suggesting dividend sustainability. Analysts average a target price near $228, implying modest upside (~7.5%), and the upcoming fiscal‑2026 earnings release on June 25 could act as a catalyst.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup with price near resistance
  • Upcoming earnings announcement adds near‑term volatility
  • Stable trading volume and low beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target price provides ~7‑8% upside
  • Consistent dividend yield and payout sustainability
  • Steady revenue growth and strong operating margins

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • High ROE and diversified restaurant portfolio
  • Attractive dividend yield for income‑focused investors
  • Long‑term brand strength offsetting leverage concerns

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin8.66%
P/E Ratio22.1
ROE51.54%
ROA7.26%
Debt/Equity387.68
P/B Ratio11.5
Op. Cash Flow$1.7B
Free Cash Flow$678.2M

Technical Analysis

TrendBullish
RSI62.1
Support$189.97
Resistance$214.14
MA 20$202.09
MA 50$198.77
MA 200$195.81
MACDBullish
VolumeStable
Fear & Greed Index92.95

Valuation

Fair Value$31.34
Target Price$226.23
Upside/Downside7.52%
GradeFair
TypeBlend
Dividend Yield2.87%

Risk Assessment

Beta0.34
Volatility24.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.